Cargando…

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes

Recent reports have revealed myelodysplastic syndromes (MDS) to arise from cancer stem cells phenotypically similar to physiological hematopoietic stem cells. Myelodysplastic hematopoiesis maintains a hierarchical organization, but the proportion of several hematopoietic compartments is skewed and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostendorf, Benjamin N., Flenner, Eva, Flörcken, Anne, Westermann, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969762/ https://www.ncbi.nlm.nih.gov/pubmed/29799854 http://dx.doi.org/10.1371/journal.pone.0197823

Ejemplares similares

Techniques for detecting chromosomal aberrations in myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation
por: Behbehani, Gregory K., et al.
Publicado: (2020)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
por: Luo, Bingqing, et al.
Publicado: (2022)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
por: Schwind, Sebastian, et al.
Publicado: (2021)

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells
por: Wang, Huafeng, et al.
Publicado: (2021)

Aberrant Methylation-Mediated Suppression of APAF1 in Myelodysplastic Syndrome
por: Zaker, Farhad, et al.
Publicado: (2017)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

P704: ABERRANT IMMUNE MICROENVIRONMENT IN BONE MARROW OF MYELODYSPLASTIC SYNDROME PATIENTS DRIVES A SUPPRESSIVE PHENOTYPE
por: Rai, Richa, et al.
Publicado: (2023)

Identification of Novel Insertions and Deletions in Haematopoietic Stem/Progenitor Cells in de novo Myelodysplastic Syndromes
por: Bandara, Manoj, et al.
Publicado: (2021)

Stem Cells in the Myelodysplastic Syndromes
por: Zhan, Di, et al.
Publicado: (2021)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
por: Paracatu, Luana Chiquetto, et al.
Publicado: (2020)

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
por: Dutta, Sayantanee, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome
por: Tatetsu, Hiro, et al.
Publicado: (2023)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
por: Rathnayake, A. J. I. S., et al.
Publicado: (2016)

Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
por: Stevens, Brett M., et al.
Publicado: (2018)

Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
por: Kataoka, Naoyuki, et al.
Publicado: (2021)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
por: Jiang, Yan, et al.
Publicado: (2021)

Phenotypic characterization of mouse mammary epithelial stem and progenitor cells
por: Stingl, J, et al.
Publicado: (2006)

Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes
por: Xing, Tong, et al.
Publicado: (2022)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Impact of Copy Neutral Loss of Heterozygosity and Total Genome Aberrations on Survival in Myelodysplastic Syndrome
por: Yeung, Cecilia, et al.
Publicado: (2017)

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
por: Do, Louis, et al.
Publicado: (2020)

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo
por: Knorr, Katherine L.B., et al.
Publicado: (2016)

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
por: Madan, Vikas, et al.
Publicado: (2015)

Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures
por: Masala, Erico, et al.
Publicado: (2018)

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome
por: Guzzi, Nicola, et al.
Publicado: (2022)

Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy
por: Shameli, Afshin, et al.
Publicado: (2020)

Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Chen, Yi-Bin, et al.
Publicado: (2009)

Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture
por: Dey, Devaveena, et al.
Publicado: (2009)

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
por: Jin, Xin, et al.
Publicado: (2018)

Hematopoietic Stem Cells (HSC) and Granulocyte Macrophage Progenitors (GMP) are the Oxidative Stress Targets in Low/Intermediate-1 Risk Myelodysplastic Syndromes
por: Giai, Valentina, et al.
Publicado: (2022)

Innovative Analyses Support a Role for DNA Damage and an Aberrant Cell Cycle in Myelodysplastic Syndrome Pathogenesis
por: Head, David R., et al.
Publicado: (2011)

Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia
por: Li, Mian-Yang, et al.
Publicado: (2015)

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes
por: Pribyl, Miroslav, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kl4pj0m9esm19n6l41jqmpjujl